Freespira

Private

Kirkland, WashingtonHealthcare & Life Scienceshttps://freespira.com/

Last Round

VC Round

Dec 8, 2020

Total Funding Raised

$12.48M

Company Overview

Freespira is a digital therapeutics company that provides an FDA-cleared, medication-free at-home treatment program for panic disorder and post-traumatic stress disorder.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical Devices, Patient Engagement

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Revenue Share

AI Layer

Non-AI

Keywords

digital therapeuticDTxbiofeedbackcapnometrypanic disorder treatmentPTSD treatmentbreathing trainingat-home therapymental health techbehavioral healthoutcomes-based pricingvalue-based careremote monitoringnon-pharmaceutical treatmentmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Freespira Comps

Public and private peers based on sector, stage, and business model.

Freespira comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Freespira Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Dec 8, 2020
Series B	Mar 3, 2016
Series A	Mar 9, 2015
Series A	Oct 2, 2013

View all Funding Rounds

Key People

Founding team and executive leadership

Debra Reisenthel

Founding CEO, Director

Founding Team

Joseph Perekupka

Chief Executive Officer

Executive Team

Freespira Investors

Notable investors and investment history

Freespira investors
Investor	Rounds
Aphelion Capital	VC Round, Series A
Medvest Capital	VC Round, Series A
Lightspeed Venture Partners	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 1, 2026
Launched fifth-generation device for at-home treatment of anxiety disorders.

View all signals

Freespira Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Freespira Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Freespira's valuation, stock price, and market status.

Firmographic Details

HeadquartersKirkland, Washington

Employee Range41

Year Founded2013

Last FundingDec 8, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.